Biotech is still open for business, but what does it really take to get funded in today’s market?
In this episode, host Elaine Hamm, PhD, is joined by special guest host James Zanewicz, JD, LLM, RTTP, the CEO of Connect, for a candid conversation on the current biotech funding landscape and what founders are up against right now. From longer timelines and more selective investors to the growing importance of relationships, differentiation, and capital strategy, they break down what’s changed for early-stage companies. Drawing from both of their experiences, they explore how founders can navigate today’s environment with sharper focus, stronger storytelling, and a more disciplined approach to execution.
In this episode, you’ll learn:

Why strong science is no longer enough, and how founders must clearly demonstrate a path to value creation and return on investment.
How to build a “patchwork” capital strategy across venture, non-dilutive funding, partnerships, and alternative sources.
What founders should prioritize today, from milestone planning and capital efficiency to operational discipline and relationship building.

Tune in to learn how to navigate a tougher biotech market, position your company for funding, and build a strategy that stands out in an increasingly competitive landscape.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.